Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus
- 20 February 2015
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 264 (1) , 121-137
Abstract
Summary: The spread of human immunodeficiency virus (HIV) infection within Africa led to marked increases in numbers of cases of tuberculosis (TB), and although the epidemic peaked in 2006, there were still 1.8 million new cases in 2013, with 29.2 million prevalent cases. Half of all TB cases in Africa are in those with HIV co‐infection. A brief review of the well‐documented main immunological mechanisms of HIV‐associated increased susceptibility to TB is presented. However, a new threat is facing TB control, which presents itself in the form of a rapid increase in the number of people living with type II diabetes mellitus (T2DM), particularly in areas that are already hardest hit by the TB epidemic. T2DM increases susceptibility to TB threefold, and the TB burden attributable to T2DM is 15%. This review addresses the much smaller body of research information available on T2DM‐TB, compared to HIV‐TB comorbidity. We discuss the altered clinical presentation of TB in the context of T2DM comorbidity, changes in innate and adaptive immune responses, including lymphocyte subsets and T‐cell phenotypes, the effect of treatment of the different comorbidities, changes in biomarker expression and genetic predisposition to the respective morbidities, and other factors affecting the comorbidity. Although significant gains have been made in improving our understanding of the underlying mechanisms of T2DM‐associated increased susceptibility, knowledge gaps still exist that require urgent attention.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1065330)
- Bill and Melinda Gates Foundation (37772)
- EU FP7 (305279)
- EU FP7 (241642)
- EU FP7 (280873)
- EU FP7 (241745)
- EU FP7 (312661)
- Netherlands Organisation of Scientific research (N/A)
This publication has 189 references indexed in Scilit:
- Common variants at 11p13 are associated with susceptibility to tuberculosisNature Genetics, 2012
- Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east AsiansNature Genetics, 2011
- Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosisTuberculosis, 2011
- Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patientsMolecular Immunology, 2011
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Antimicrobial activity of mucosal-associated invariant T cellsNature Immunology, 2010
- The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and HumansCell, 2010
- Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cellsEuropean Journal of Immunology, 2009
- Genetic deficiencies of innate immune signalling in human infectious diseaseThe Lancet Infectious Diseases, 2009
- Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populationsEuropean Journal of Immunology, 2007